CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons
Tefferi, A, Lasho, T L, Finke, C M, Knudson, R A, Ketterling, R, Hanson, C H, Maffioli, M, Caramazza, D, Passamonti, F, Pardanani, A
Published in Leukemia (01.07.2014)
Published in Leukemia (01.07.2014)
Get full text
Journal Article
CALR and ASXL1 mutations-based molecular prognostication in primary myelofibrosis: an international study of 570 patients
Tefferi, A, Guglielmelli, P, Lasho, T L, Rotunno, G, Finke, C, Mannarelli, C, Belachew, A A, Pancrazzi, A, Wassie, E A, Ketterling, R P, Hanson, C A, Pardanani, A, Vannucchi, A M
Published in Leukemia (01.07.2014)
Published in Leukemia (01.07.2014)
Get full text
Journal Article
Type 1 vs type 2 calreticulin mutations in primary myelofibrosis: differences in phenotype and prognostic impact
Tefferi, A, Lasho, T L, Finke, C, Belachew, A A, Wassie, E A, Ketterling, R P, Hanson, C A, Pardanani, A
Published in Leukemia (01.07.2014)
Published in Leukemia (01.07.2014)
Get full text
Journal Article
Safety and efficacy of CYT387, a JAK1 and JAK2 inhibitor, in myelofibrosis
Pardanani, A, Laborde, R R, Lasho, T L, Finke, C, Begna, K, Al-Kali, A, Hogan, W J, Litzow, M R, Leontovich, A, Kowalski, M, Tefferi, A
Published in Leukemia (01.06.2013)
Published in Leukemia (01.06.2013)
Get full text
Journal Article
The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients
Guglielmelli, P, Lasho, T L, Rotunno, G, Score, J, Mannarelli, C, Pancrazzi, A, Biamonte, F, Pardanani, A, Zoi, K, Reiter, A, Duncombe, A, Fanelli, T, Pietra, D, Rumi, E, Finke, C, Gangat, N, Ketterling, R P, Knudson, R A, Hanson, C A, Bosi, A, Pereira, A, Manfredini, R, Cervantes, F, Barosi, G, Cazzola, M, Cross, N C P, Vannucchi, A M, Tefferi, A
Published in Leukemia (01.09.2014)
Published in Leukemia (01.09.2014)
Get full text
Journal Article
Clinical correlates of JAK2V617F presence or allele burden in myeloproliferative neoplasms: a critical reappraisal
Vannucchi, A M, Antonioli, E, Guglielmelli, P, Pardanani, A, Tefferi, A
Published in Leukemia (01.07.2008)
Published in Leukemia (01.07.2008)
Get full text
Journal Article
CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia
Pardanani, A, Lasho, T L, Laborde, R R, Elliott, M, Hanson, C A, Knudson, R A, Ketterling, R P, Maxson, J E, Tyner, J W, Tefferi, A
Published in Leukemia (01.09.2013)
Published in Leukemia (01.09.2013)
Get full text
Journal Article
Risk factors for arterial versus venous thrombosis in polycythemia vera: a single center experience in 587 patients
Cerquozzi, S, Barraco, D, Lasho, T, Finke, C, Hanson, C A, Ketterling, R P, Pardanani, A, Gangat, N, Tefferi, A
Published in Blood cancer journal (New York) (27.12.2017)
Published in Blood cancer journal (New York) (27.12.2017)
Get full text
Journal Article
Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study
Tefferi, A, Rumi, E, Finazzi, G, Gisslinger, H, Vannucchi, A M, Rodeghiero, F, Randi, M L, Vaidya, R, Cazzola, M, Rambaldi, A, Gisslinger, B, Pieri, L, Ruggeri, M, Bertozzi, I, Sulai, N H, Casetti, I, Carobbio, A, Jeryczynski, G, Larson, D R, Müllauer, L, Pardanani, A, Thiele, J, Passamonti, F, Barbui, T
Published in Leukemia (01.09.2013)
Published in Leukemia (01.09.2013)
Get full text
Journal Article
Concomitant analysis of EZH2 and ASXL1 mutations in myelofibrosis, chronic myelomonocytic leukemia and blast-phase myeloproliferative neoplasms
ABDEL-WAHAB, O, PARDANANI, A, PATEL, J, WADLEIGH, M, LASHO, T, HEGUY, A, BERAN, M, GILLILAND, D. G, LEVINE, R. L, TEFFERI, A
Published in Leukemia (01.07.2011)
Published in Leukemia (01.07.2011)
Get full text
Journal Article
Prognostic significance of ASXL1 mutation types and allele burden in myelofibrosis
Tefferi, A, Lasho, T L, Finke, C, Gangat, N, Hanson, C A, Ketterling, R P, Pardanani, A
Published in Leukemia (01.03.2018)
Published in Leukemia (01.03.2018)
Get full text
Journal Article
Calreticulin mutations and long-term survival in essential thrombocythemia
Tefferi, A, Wassie, E A, Lasho, T L, Finke, C, Belachew, A A, Ketterling, R P, Hanson, C A, Pardanani, A, Gangat, N, Wolanskyj, A P
Published in Leukemia (01.12.2014)
Published in Leukemia (01.12.2014)
Get full text
Journal Article
Mutations and prognosis in primary myelofibrosis
Vannucchi, A M, Lasho, T L, Guglielmelli, P, Biamonte, F, Pardanani, A, Pereira, A, Finke, C, Score, J, Gangat, N, Mannarelli, C, Ketterling, R P, Rotunno, G, Knudson, R A, Susini, M C, Laborde, R R, Spolverini, A, Pancrazzi, A, Pieri, L, Manfredini, R, Tagliafico, E, Zini, R, Jones, A, Zoi, K, Reiter, A, Duncombe, A, Pietra, D, Rumi, E, Cervantes, F, Barosi, G, Cazzola, M, Cross, N C P, Tefferi, A
Published in Leukemia (01.09.2013)
Published in Leukemia (01.09.2013)
Get full text
Journal Article
IDH1 and IDH2 mutation analysis in chronic- and blast-phase myeloproliferative neoplasms
PARDANANI, A, LASHO, T. L, FINKE, C. M, MAI, M, MCCLURE, R. F, TEFFERI, A
Published in Leukemia (01.06.2010)
Published in Leukemia (01.06.2010)
Get full text
Journal Article
Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS/MPN and AML
Tefferi, A, Lim, K-H, Abdel-Wahab, O, Lasho, T L, Patel, J, Patnaik, M M, Hanson, C A, Pardanani, A, Gilliland, D G, Levine, R L
Published in Leukemia (01.07.2009)
Published in Leukemia (01.07.2009)
Get full text
Journal Article